Language

English

Publication Date

12-31-2026

Journal

Gut Microbes

DOI

10.1080/19490976.2026.2657049

PMID

41986915

PMCID

PMC13085939

PubMedCentral® Posted Date

4-15-2026

PubMedCentral® Full Text Version

Post-print

Abstract

Many professional organizations publish clinical practice guidelines for the use of probiotics in gastrointestinal disorders. Generally, no two guidelines align perfectly, and some differ markedly. These discrepancies occur because clinical practice guidelines are not purely mechanical outputs of data synthesis. They are shaped by structured interpretation, value judgments, and predefined thresholds for uncertainty. These elements become particularly visible when effect sizes are small, heterogeneity is high, and outcomes vary in clinical relevance-as is the case with probiotic research. This article examines why discordance among probiotic guidelines is predictable and provides practical guidance for clinicians who must decide among conflicting recommendations to make the most appropriate management decisions for their patients. Guidance is also provided for investigators who seek to improve the quality of evidence, confidence in recommendations, and accurate communication of probiotic research to clinicians, patients, and the broader scientific ecosystem.

Keywords

Probiotics, Humans, Practice Guidelines as Topic, Gastrointestinal Diseases, Certainty of evidence, necrotizing enterocolitis, network meta-analysis, systematic reviews

Published Open-Access

yes

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.